Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: Results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial

GO-FURTHER investigators

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: Results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds